Holly Hartman

Holly Hartman, PhD, is an Assistant Professor in the Department of Population and Quantitative Health Sciences at Case Western Reserve University School of Medicine. Her research focuses on leveraging biostatistical methods to improve clinical trial design and analysis, particularly in oncology. She is a member of the Population and Cancer Prevention Program at the Case Comprehensive Cancer Center.

Dr. Hartman holds a PhD in Biostatistics from the University of Michigan (2021), an MS in Biostatistics from the University of Alabama (2016), and a BS in Mathematics and Molecular & Cellular Biology from the University of Puget Sound (2011). Her work emphasizes addressing racial disparities in prostate cancer outcomes and optimizing radiation therapy approaches.

Her research interests include clinical trial methodology, health disparities, and the integration of social determinants of health into oncology research. Recent studies have explored PSA screening policies, racial inequities in prostate cancer care, and the efficacy of androgen deprivation therapy in localized prostate cancer treatment.

Dr. Hartman is affiliated with the Wolstein Research Building and Robbins Building facilities at Case Western Reserve University. She actively contributes to professional organizations including the American Statistical Association and the International Biometrics Society.